CA2353797A1 - Proteines associees a des neurones - Google Patents

Proteines associees a des neurones Download PDF

Info

Publication number
CA2353797A1
CA2353797A1 CA002353797A CA2353797A CA2353797A1 CA 2353797 A1 CA2353797 A1 CA 2353797A1 CA 002353797 A CA002353797 A CA 002353797A CA 2353797 A CA2353797 A CA 2353797A CA 2353797 A1 CA2353797 A1 CA 2353797A1
Authority
CA
Canada
Prior art keywords
neuap
polynucleotide
sequence
sequences
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002353797A
Other languages
English (en)
Inventor
Y. Tom Tang
Henry Yue
Mariah R. Baughn
Jennifer L. Hillman
Preeti Lal
Janice Au-Young
Junming Yang
Dyung Aina M. Lu
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2353797A1 publication Critical patent/CA2353797A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des protéines associées à des neurones humaines (NEUAP) et des polynucléotides qui identifient et codent des NEUAP. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. L'invention porte aussi sur des méthodes de diagnostic, de traitement, ou de prévention de troubles associés à l'expression des NEUAP.
CA002353797A 1998-12-11 1999-12-10 Proteines associees a des neurones Abandoned CA2353797A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US21008398A 1998-12-11 1998-12-11
US09/210,083 1998-12-11
US11936599P 1999-02-09 1999-02-09
US60/119,365 1999-02-09
US12468799P 1999-03-16 1999-03-16
US60/124,687 1999-03-16
PCT/US1999/030408 WO2000034477A2 (fr) 1998-12-11 1999-12-10 Proteines associees a des neurones
USUNKNOWN 2009-02-19

Publications (1)

Publication Number Publication Date
CA2353797A1 true CA2353797A1 (fr) 2000-06-15

Family

ID=27382298

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002353797A Abandoned CA2353797A1 (fr) 1998-12-11 1999-12-10 Proteines associees a des neurones

Country Status (5)

Country Link
EP (1) EP1135494A2 (fr)
JP (1) JP2003518913A (fr)
AU (1) AU2373800A (fr)
CA (1) CA2353797A1 (fr)
WO (1) WO2000034477A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ525914A (en) * 1998-03-10 2004-03-26 Genentech Inc Novel polypeptides and nucleic acids encoding the same
US7723488B2 (en) 1998-03-27 2010-05-25 Genentech, Inc. Monoclonal antibodies to secreted and transmembrane polypeptides
PT1626058E (pt) * 1999-03-08 2008-02-15 Genentech Inc Composições e métodos para o diagnóstico de tumores
US7129324B2 (en) * 1999-06-22 2006-10-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
RU2002110275A (ru) * 2000-08-22 2004-03-27 Дзе Брихэм Энд Уимен'З Хоспитал, Инк. (Us) Диагностика и лечение сердечно-сосудистых состояний
US20030207801A1 (en) * 2000-10-23 2003-11-06 Valerie Gerlach Novel polypeptides and nucleic acids encoding same
KR100945383B1 (ko) 2001-05-25 2010-03-05 니목스 코포레이션 종양 및 세포의 제거 또는 파괴를 필요로 하는 다른질환의 치료에 효과적인 펩티드
WO2003008444A2 (fr) 2001-07-19 2003-01-30 Nymox Corporation Peptides efficaces pour le traitement de tumeurs ou autres maladies necessitant l'ablation ou la destruction de cellules
EP1847550A3 (fr) * 2001-07-19 2008-01-09 Nymox Corporation Peptides actives dans le traitement des tumeurs et autre conditions requérant la suppression ou la destruction de cellules
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EP2311468B1 (fr) 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gène surexprimé dans le cancer
MXPA06011851A (es) 2004-04-14 2006-12-14 Genentech Inc Composiciones y metodos para moduilar el desarrollo vascular.
US8147817B2 (en) 2006-05-04 2012-04-03 The Brigham And Women's Hospital, Inc. IL-33 in the treatment and diagnosis of diseases and disorders
PE20120902A1 (es) 2009-05-08 2012-08-08 Genentech Inc Anticuerpos anti-egfl7 humanizados
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
WO2022011284A1 (fr) * 2020-07-10 2022-01-13 Ohio State Innovation Foundation Peptide de type facteur de croissance épidermique 7 et utilisations associées

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512016A (ja) * 1997-08-01 2001-08-21 ジェンセット 筋肉およびその他中胚葉組織中で発現される分泌タンパク質の５’ｅｓｔ

Also Published As

Publication number Publication date
WO2000034477A3 (fr) 2000-11-09
AU2373800A (en) 2000-06-26
JP2003518913A (ja) 2003-06-17
EP1135494A2 (fr) 2001-09-26
WO2000034477A2 (fr) 2000-06-15

Similar Documents

Publication Publication Date Title
CA2353797A1 (fr) Proteines associees a des neurones
CA2342833A1 (fr) Proteines gpcr humaines
CA2417587A1 (fr) Transporteurs et canaux ioniques
CA2327259A1 (fr) Molecules de regulateur de transcription humaine
CA2338386A1 (fr) Proteases et proteines associees
CA2349818A1 (fr) Proteines de transport membranaire
CA2379968A1 (fr) Proteines associees de liaison gtp
CA2363684A1 (fr) Proteines de secretion humaines
US6248594B1 (en) Kinesin-like motor protein
CA2375493A1 (fr) Proteines de transport humaines
CA2359701A1 (fr) Proteines liant des acides nucleiques
CA2410084A1 (fr) Transporteurs et canaux ioniques
CA2405781A1 (fr) Proteines secretees
WO2000020590A2 (fr) Proteines de recepteurs couples a des proteines g
CA2329053A1 (fr) Proteines socs humaines
CA2401113A1 (fr) Transporteurs et canaux ioniques
CA2443897A1 (fr) Transporteurs et canaux ioniques
CA2449440A1 (fr) Proteines structurelles et associees au cytosquelette
US20040249128A1 (en) Molecules for disease detection and treatment
CA2438206A1 (fr) Transporteurs et canaux ioniques
CA2370195A1 (fr) Proteines humaines associees aux membranes
CA2463000A1 (fr) Proteines associees aux vesicules
CA2384324A1 (fr) Proteines associees a la differenciation cellulaire
CA2332309A1 (fr) Proteines associees a la neurotransmission
CA2340277A1 (fr) Proteines humaines associees a l'arn

Legal Events

Date Code Title Description
FZDE Dead